On September 24, 2022, John Bolger notified the Board of Directors of Fulgent Genetics, Inc. (the Company) of his decision to resign from the Board. Mr. Bolger resigned as the Chair of the Audit Committee and member of the Compensation Committee and Nominating and Corporate Governance Committee, effective as of September 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.39 USD | +1.18% | -3.26% | -26.01% |
05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.01% | 640M | |
-23.07% | 7.86B | |
+68.36% | 4.32B | |
+1.88% | 2.63B | |
-8.06% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.18% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Announces Resignation of John Bolger from the Board